Connect with us

Media OutReach

The National University Hospital and Ruijin Hospital, Shanghai Jiao Tong University School of Medicine establish key partnership for collaborative healthcare innovations

Published

on

Through the newly-formed Singapore-Shanghai Medical Innovation Centre, clinicians from both hospitals partner to advance breakthroughs in cell and gene therapy and orthopaedics for a start

SINGAPORE – Media OutReach Newswire – 16 October 2025 – In a step towards charting a new chapter in patient-centred innovations, the National University Hospital (NUH) and the Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (RJH) formally launched the Singapore-Shanghai Medical Innovation Centre (SSMIC) on 15 October at the 6th Singapore-Shanghai Comprehensive Cooperation Council (SSCCC) meeting in Shanghai, China.

Adj Prof Mark Edward Puhaindran, Chairman, Medical Board, National University Hospital (seated, third from left) and Prof Ning Guang, President, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine (seated, fourth from left), at the launch of the Singapore-Shanghai Medical Innovation Centre on 15 Oct 2025.

The SSMIC marks the first project arising from the Memorandum of Understanding (MOU) signed by both hospitals during the 5th SSCCC meeting in 2024 , to establish a framework for clinical cooperation through staff exchange programmes and other collaborative efforts.
Co-chaired by Professor Aymeric Lim, Chief Executive Officer of NUH, and Professor Ning Guang, President of RJH, the SSMIC will serve as a dynamic space dedicated to co-developing proof-of-concept methodologies and medical technologies, exchange of critical expertise and ideas, and conducting vital translational research.
Elevating the patient care landscape
To begin this collaborative journey, the SSMIC will focus its efforts on priority tracks that draw upon the strengths and expertise of both NUH and RJH. This focused approach aims to deliver tangible results and accelerate innovations that will directly benefit patients, beginning with:
  • Cell and gene therapy
  • 3D printing in orthopaedics
Under cell and gene therapy, cancer experts from both hospitals will jointly conduct clinical trials to validate a novel Chimeric Antigen Receptor (CAR) T-cell therapy. Using a patient’s own immunity system to fight the cancer, this therapy employs a highly personalised form of treatment to destroy the cancer cells with the specific biomarker on their surface. The objective of this collaboration is to translate the findings of the trials into a validated, effective treatment that can be made available to suitable cancer patients, especially those who have not found success with first-line cancer treatments.
In the field of orthopaedics, specialists from NUH and RJH will launch a collaborative clinical study focusing on 3D printing’s transformative potential for musculoskeletal tumour resection and reconstruction of affected areas in patients’ bodies, to enhance surgical outcomes and improve patient recovery. This includes the design and implementation of patient-specific tumour prostheses, development of advanced 3D-printed bone-ingrowth segment scaffolds, and the use of bioprinted materials to address complex reconstructive needs arising from challenging cases such as after the removal of a large tumour.
While these initial projects represent a significant first step, they are just the beginning of what SSMIC sets out for patients. With the Centre designed to be a dynamic and sustained platform, NUH and RJH will actively explore opportunities for further collaborations and expand the Centre’s scope, ensuring a sustained pipeline of clinical breakthroughs.
“In the face of ever-evolving health challenges, it is paramount that we continuously innovate and push the boundaries of medical science” said Professor Aymeric Lim. “We are honoured to formalise this partnership with RJH as we build upon the foundation of collaboration established as founding members of the Asian University Hospital Alliance and as co-hosts at the 3rd Asian University Health Forum in December this year. Through the SSMIC, we look forward to partnering with RJH with a common mission to advance real-world change in healthcare, enriching the lives of individuals in both countries and beyond.”
“NUH shares the same value with Ruijin Hospital regardless of the geographic distance so our employees will do all we can to advance the clinical care and research to benefit more patients in more countries. Clinical excellence relies on long-term investment in people and lifelong reverence for the unknown. We as physicians and surgeons shall dedicate all we learn to the new cures; and mobilise the industry, the regulators, the basic scientists and other stakeholders to apply these cures to human at the fastest speed. This is also the call of SSMIC. With the support from Shanghai government and Singapore stakeholders, I have the faith that we will succeed.” said Professor NING Guang, President of Ruijin Hospital.

Hashtag: #NationalUniversityHospital




The issuer is solely responsible for the content of this announcement.

About the National University Hospital

The National University Hospital (NUH) is Singapore’s leading university hospital. While the hospital at Kent Ridge first received its patients on 24 June 1985, our legacy started from 1905, the date of the founding of what is today the NUS Yong Loo Lin School of Medicine. NUH is the principal teaching hospital of the medical school.
Our unique identity as a university hospital is a key attraction for healthcare professionals who aspire to do more than practise tertiary medical care. We offer an environment where research and teaching are an integral part of medicine, and continue to shape medicine and transform care for the community we care for.
We are an academic medical centre with over 1,200 beds, serving more than one million patients a year with over 50 medical, surgical and dental specialties. NUH is the only public and not-for-profit hospital in Singapore to provide trusted care for adults, women and children under one roof, including the only paediatric kidney and liver transplant programme in the country.
The NUH is a key member of the National University Health System (NUHS), one of three public healthcare clusters in Singapore.

About Ruijin Hospital, Shanghai Jiao Tong University School of Medicine

Ruijin Hospital was founded in 1907, formerly known as “Kuang-tse Hospital 廣慈醫院” and “Hôpital Sainte-Marie”, and is a public teaching hospital of Shanghai Jiao Tong University. The hospital boasts numerous medical experts with a high reputation both at home and abroad and runs full clinical specialties in Shanghai, Zhejiang, Jiangsu and Hainan Provinces. The headquarter is located in the city center of Shanghai City where the garden campus offers assuring mental and physical care for the people. Leading with solid research accomplishment and always curing the incurable, our faculty always meets the challenges in the no man’s land of medical technology. By mastering the cutting-edge therapy and adopting the team approach, we unite our strengths for the multidisciplinary treatment on the patients.
Ruijin Hospital established the official collaboration in 2024 under the government framework between Shanghai and Singapore. This partnership marks the fruit of the long-lasting medical exchange in two cities. Aiming to tackle more unmet needs in clinical, Ruijin Hospital will join NUH for more advanced cure in Asia and beyond.

Advertisement

Media OutReach

XIXILI Reimagines Plus-Size Lingerie in Malaysia

Published

on

KUALA LUMPUR, MALAYSIA – Media OutReach Newswire – 6 December 2025 – XIXILI is rewriting the rules of lingerie shopping with its Plus Size Collection, moving beyond the typical S, M, L, XL approach that leaves so many women without options. The brand’s extensive range proves that well-fitted, beautiful lingerie shouldn’t be a luxury reserved for a select few.

When One Size Definitely Doesn’t Fit All

XIXILI’s Plus Size Collection flips the narrative that women need to settle for less-than-ideal sizes.

“For too many women, bra shopping has meant settling for sizes that almost fit or styles that prioritise function over fashion,” says XIXILI spokesperson Grace Tan. “Inclusivity is about recognising that every woman deserves access to beautiful, sexy, well-fitted lingerie. That shouldn’t be a problem they have to solve alone.”

To address the challenges of online fitting, XIXILI combines a detailed bra size chart with its pioneering ‘Try-On in 3D’ avatar tool. The feature allows women to generate a personalised digital twin based on specific measurements, enabling them to visualise the fit before purchasing.

Support Without Sacrifice: Plus Size Done Right

The Rufina Full Coverage Full Cup Bra sits at the heart of XIXILI’s Plus Size collection, designed for women who have been told they have to choose between support and style. The Rufina bra offers full coverage support with a contemporary silhouette that works under everything from work blouses to festive party dresses. Engineered specifically for fuller figures, it celebrates natural curves instead of trying to hide or minimise them. It’s the kind of foundation piece that lets you focus on your day, not your discomfort.

“We want every woman to feel supported, comfortable, and beautiful in whatever she’s wearing,” says Grace Tan. “Whether it’s for work, family gatherings, or special occasions, the right fit makes all the difference to daily comfort and confidence.”

Empowering Women With Knowledge, Not Just Options

XIXILI recognises that offering more sizes is only half the equation. Many women have spent years navigating limited options without proper guidance on finding their actual measurements.

The brand addresses this through interactive bra size charts, how-to-measure videos, and one-on-one personalised fittings at boutiques nationwide. By equipping women with the tools and knowledge to identify their true size, XIXILI transforms what can be a frustrating shopping experience into a more confident and informed process.

As Christmas shopping gets underway, the Plus Size Collection offers both a thoughtful gift for loved ones and an opportunity for self-care during the busy holiday season.

For more information and to discover the full range, visit XIXILI’s website.

Hashtag: #XIXILI





The issuer is solely responsible for the content of this announcement.

XIXILI

A homegrown Malaysian brand, XIXILI offers beautiful fashion lingerie and shapewear in Malaysia that prioritises fit and comfort. With an extensive range of bra sizes from A to I and bands 65 to 110cm, XIXILI caters to women of all shapes and sizes. Expert fitters are dedicated to helping each customer find the perfect bra, boosting confidence and enhancing silhouettes.

XIXILI became the first Malaysian lingerie brand to introduce a Try-On in 3D avatar tool, allowing customers to virtually try on XIXILI lingerie using a 3D avatar tailored to their specific body type and measurements. Whether for everyday wear or something special, XIXILI ensures women always look and feel amazing.

Continue Reading

Media OutReach

Essential Document Checklist for SIM Applications

Published

on

SINGAPORE – Media OutReach Newswire – 6 December 2025 – Submitting an application to the Singapore Institute of Management (SIM) represents a significant academic milestone and requires meticulous preparation. Incomplete or missing documentation may result in processing delays or possible rejection. To assist applicants in meeting these requirements, this guide provides a detailed overview based on SIM’s official application standards.

Preparation Is Key

SIM reviews thousands of applications each year, and incomplete submissions remain one of the primary causes of processing delays. Early preparation of all required documents is essential to ensure a seamless application experience and allow applicants to remain focused on their academic objectives. As stipulated in SIM’s Application Process Guide, all supporting documents must be uploaded at the point of application and submissions lacking these documents will not be processed.

The Core Documents Every Applicant Needs

Prior to applying to the Singapore Institute of Management (SIM), applicants should ensure that all required documents are prepared to prevent processing delays. Scanned copies of academic certificates and transcripts, such as GCE ‘O’ and ‘A’ Levels, diplomas or degrees must be provided, along with certified translations and notarisation for documents not in English.

Proof of English language proficiency, such as IELTS or TOEFL results, is mandatory for applicants whose previous education was not conducted in English. Identification documents are also required, including the NRIC for local applicants and a valid passport for international applicants, accompanied by a recent passport-sized photograph that complies with SIM’s specifications.

International applicants must additionally prepare documentation for the Student’s Pass application, which includes the passport bio-data page, birth certificate, evidence of financial capability, and, where applicable, parent or guardian identification documents.

Quick Tips to Avoid Delays

Submitting an application to the SIM can be a straightforward process with proper preparation. Ensure that all documents are uploaded in the correct format, with PDF being the standard for certificates and transcripts. For documents not in English, certified translations must be provided to prevent rejection or requests for re-submission.

Applicants should also adhere to SIM’s photo specifications by submitting a recent passport-sized photograph that meets official guidelines. International students must pay particular attention to financial documentation, as proof of financial capability is a key requirement for the Student’s Pass application. Bank statements and supporting documents should be prepared in advance to comply with Immigration & Checkpoints Authority (ICA) requirements. Following these steps will help avoid unnecessary delays and ensure a smooth application process.

Application Essentials

Prospective students are advised to submit a complete and accurate application to ensure smooth processing. Detailed instructions and programme-specific requirements can be found on SIM’s official application portal. Applications that are incomplete or contain inaccuracies will not be considered. To avoid delays, applicants should make use of the provided checklist and guidelines to confirm compliance before submission.

References:

  1. SIM Application Process – https://www.sim.edu.sg/degrees-diplomas/admissions/application-process

Hashtag: #SIMGlobalEducation #SIMGE

The issuer is solely responsible for the content of this announcement.

About SIM Global Education

SIM Global Education (SIM GE) is a leading private education institution in Singapore and the region. We offer more than 140 academic programmes ranging from diplomas and graduate diploma programmes to bachelor’s and master’s degree programmes with some of the world’s most reputable universities from Australia, Canada, Europe, United Kingdom, and the United States. SIM GE’s cohort is made up of 16,000 full- and part-time students and adult learners, of which approximately 36% are international students hailing from over 50 countries.

SIM GE’s holistic learning approach and culturally diverse learning environment aim to equip students with knowledge, industry skills and employability competencies, as well as a global perspective to succeed as future leaders in a fast-changing, technologically driven world.

For more information on SIM Global Education, visit sim.edu.sg

Continue Reading

Media OutReach

Vinfuture 2025 Honors Four Groundbreaking Scientific Achievements Under The Theme “Rising And Thriving”

Published

on

HANOI, VIETNAM – Media OutReach Newswire – 5 December 2025 – The VinFuture Foundation officially announces the laureates of the VinFuture Prizes 2025. Four outstanding scientific and technological breakthroughs have been honored, reflecting this year’s theme “Rising and Thriving”, and highlighting the role of cross-border scientific collaboration in addressing global challenges in health, environment, and human livelihood.

The Chairman of the National Assembly of Vietnam, Mr. Tran Thanh Man, presents the VinFuture 2025 Grand Prize, worth USD 3 million, to the laureate scientists.

The 2025 VinFuture Prize Award Ceremony was broadcast live on VTV1, the national television channel of Vietnam. The event was attended by Mr. Tran Thanh Man, Politburo member and Chairman of the National Assembly, along with leaders of central ministries and agencies, representatives of embassies and international organisations, and distinguished scientists from around the world.

The VinFuture Prize 2025 received 1,705 nominations from scientists, research institutions, and technology enterprises worldwide, representing an almost threefold increase relative to the inaugural year. These submissions highlight impactful cross-border research efforts focused on protecting public health, advancing next-generation intelligent materials, addressing climate change, accelerating novel energy solutions, and strengthening global food security frameworks.

The 2025 VinFuture Grand Prize valued at US$3 million is awarded to Dr. Douglas R. Lowy, Dr. John T. Schiller, Dr. Aimée R. Kreimer and Prof. Maura L. Gillison (USA) for discoveries and development of HPV vaccines for prevention of tumors caused by human papillomaviruses.

Foundational studies on HPV capsid proteins by Drs. Douglas Lowy and John Schiller led to the development of highly effective HPV vaccines, preventing millions of cervical cancer cases, especially in developing countries. Furthermore, the single-dose vaccination regimen developed by Dr. Aimée Kreimer – now recommended by the World Health Organization (WHO) – has significantly expanded vaccine access for populations worldwide.

In parallel, laboratory and epidemiological studies by Prof. Maura Gillison and Dr. Aimée Kreimer established the link between HPV and head-and-neck cancers, which represent an emerging cancer threat expected to be mitigated by HPV vaccination efforts. The achievements of Dr. Douglas Lowy, Dr. John Schiller, Dr. Aimée Kreimer, and Prof. Maura Gillison have already saved millions of lives and will keep lowering the global cancer burden for decades to come.

In addition to the Grand Prize, the 2025 VinFuture Prizes will also present three Special Prizes, each valued at US$500,000, recognizing Innovators from Developing Countries, Women Innovators, and Innovators with Outstanding Achievements in Emerging Fields.

The 2025 VinFuture Special Prize for Innovators from Developing Countries​ is awarded to Prof. María Esperanza Martínez-Romero (Mexico) for advances in microbial ecology and symbiotic nitrogen fixation in the tropics. Prof. Martínez-Romero has discovered and described numerous new Rhizobium species, significantly expanding scientific understanding of microbial taxonomy and plant-microbe interactions in agriculture. Her work has opened new directions in the study of bacterial-plant symbiosis, with profound implications for sustainable agriculture in resource-limited settings.

The 2025 VinFuture Special Prize for Women Innovators is awarded to Prof. Mary-Claire King (USA) for identification of the breast and ovarian cancer susceptibility gene BRCA1, laying the foundation for genetic testing, screening programs, and personalized treatment. Her landmark identification of the BRCA1 locus on chromosome 17q21 in 1990, before the human genome was sequenced, is considered a historic milestone, demonstrating the genetic basis of cancer risk and transforming prevention and treatment strategies worldwide.

The 2025 VinFuture Special Prize for Innovators with Outstanding Achievements in Emerging Fields has honored Prof. Venkatesan Sundaresan (USA), Prof. Raphaël Mercier (Germany), Dr. Emmanuel Guiderdoni (France), Dr. Imtiyaz Khanday (USA) and Dr. Delphine Mieulet (France) for innovations in the development of clonal hybrid crops. Hybrid seed production for rice, the staple food for more than half of humankind, is a laborious and costly procedure resulting in a high seed cost. The team’s work has enabled rice plants to produce seeds that retain all the superior traits of the parent plant through self-pollination, grounded in new insights into developmental biology and genetics. This groundbreaking research improves yields, reduces seed production costs, and advances sustainable global food security.

Sharing his reflections on this year’s honored works, Prof. Sir. Richard Friend, Chair of the VinFuture Prize Council, stated: “The 2025 VinFuture Prize Laureates have made big advances in science that have brought direct benefits to human health and to global sustainable food crop production. From new vaccines and new understanding of genetic susceptibility to disease to new approaches for plant breeding and new protocols for healthy crop growth, these achievements exemplify the power of science driven by compassion and cross-border collaboration – showing that when knowledge serves humanity, it not only deepens our understanding of the world but also strengthens and sustains the very foundations of life itself.

After five consecutive and widely acclaimed award cycles, the VinFuture Prize has been securing recognition among the world’s most prestigious science and technology awards, receiving 6,132 nominations from nearly 110 countries and territories across five continents, and honoring 48 outstanding laureates. The awarded innovations—spanning clean energy, artificial intelligence, biomedical technologies, and transformative advances in agriculture—are elevating quality of life, strengthening human well-being, and shaping strategic pathways for the future of humanity.

The VinFuture Prize Ceremony and VinFuture Sci-Tech Week have evolved into an established global platform for scientific exchange, bringing together scientists, policymakers, and business leaders to advance collaborations toward a sustainable, humane, and prosperous future.

Notably, after five award seasons driven by persistent efforts to connect global scientific excellence with the Vietnamese research community, the VinFuture Foundation and the VinFuture Prize have not only fostered new opportunities and momentum for national science, but have also strengthened Vietnam’s standing as a trusted destination for the world’s scientific community—where innovation is widely shared and amplified for the collective prosperity of humankind.

Launch of the 2026 VinFuture Prize Award Season: The VinFuture Prize 2026 will officially open its nomination portal from 2:00 PM on January 9, 2026, to 2:00 PM on April 17, 2026 (Hanoi time, GMT+7). Nominating partners are invited to submit candidate information through the online nomination portal at: https://vinfutureprize.org/vinfuture-prize-nomination/.

Hashtag: #Vinfuture

The issuer is solely responsible for the content of this announcement.

Continue Reading

Trending